- Accretive Health (AH) is facing delistment from the NYSE before markets open on Monday after saying that it expects to miss a March 19 deadline to file restated financial reports.
- In March last year, Accretive Health's audit committee ordered the company to restate results due to errors related to the timing of revenue recognition.
- While Accretive Health works on its earnings, it will trade over the counter.
- Shares are -12.1% premarket. (PR)